HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ketazolam (Marcen)

structure

Also Known As:

Marcen; MI 49001; Sedotime; Solatran; U 28,774; Unakalm; 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4H-(1,3)oxazino(3,2-d)(1,4)benzodiazepine-4,7(6H)-dione

Networked: 5 relevant articles (2 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzazepines: 5
      - Benzodiazepines: 8452
        ketazolam: 5

Experts

1.	García-Pinillos, Felipe: 1 article (01/2021)
2.	Latorre-Román, Pedro A: 1 article (01/2021)
3.	Marco-Contreras, Luis A: 1 article (01/2021)
4.	Marcén-Cinca, Noel: 1 article (01/2021)
5.	Roche-Seruendo, Luis E: 1 article (01/2021)

Related Diseases

1.	Multiple Sclerosis 11/01/1984 - "Ketazolam is a relatively safe and clinically effective antispasticity agent (especially for patients with multiple sclerosis). " 08/01/1986 - "This double-blind cross-over study of 14 severely spastic inpatients with chronic multiple sclerosis reveals that once-daily doses of ketazolam, a new drug, are effective in reducing spasticity in a significant proportion of patients without significant side-effects. "
2.	Muscle Spasticity (Spastic) 08/01/1986 - "This double-blind cross-over study of 14 severely spastic inpatients with chronic multiple sclerosis reveals that once-daily doses of ketazolam, a new drug, are effective in reducing spasticity in a significant proportion of patients without significant side-effects. "
3.	Anxiety Disorders (Anxiety Disorder) 01/01/1988 - "In a multicenter, double-blind trial, 63 elderly patients who had experienced a generalized anxiety disorder for at least one month were randomly assigned to receive 15 mg of ketazolam (n = 31) or placebo (n = 32) daily for 15 days. " 01/01/1988 - "A multicenter, double-blind, between-patient trial comparing two doses of ketazolam (15 and 30 mg) with placebo, each given once daily, in the evening, to 92 outpatients affected by generalized anxiety disorders for at least 1 month, was carried out. "
4.	Cryopyrin-Associated Periodic Syndromes 01/01/2021 - "García-Pinillos, F, Roche-Seruendo, LE, Marcen-Cinca, N, Marco-Contreras, LA, and Latorre-Román, PA. "